Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Zosano Pharma Corp (ZSAN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-22Dec-31-21Sep-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Jun-05-20
   10-Q10-K10-Q10-Q10-K10-Q10-Q8-K
Service revenue  0.10.10.30.30.2  4.9
            Service revenue growth  -48.8%-61.2%     -25.7%
Operating expenses:          
Cost of service revenue  0.10.10.30.2    
Research and development  4.54.76.05.35.45.84.9 
General and administrative  2.92.32.52.82.62.72.82.8
Impairment loss  25.9       
    Total operating expenses  33.57.08.88.38.28.5  
    Loss from operations  -33.3-6.9-8.6-8.0-7.9-8.5-7.7-7.7
            Operating margin  -25240.9%-7950.6%-3410.7%-3119.4%   -156.1%
   
Other income (expense):          
Interest income  0.00.00.00.00.00.00.0 
Interest expense  -0.1-0.10.0-0.1-0.2-0.2-0.2-0.2
Other income (expense), net  0.00.0-0.10.00.00.00.0 
    Loss before provision for income taxes  -33.4-7.0-8.7-8.1-8.1-8.7-7.9 
Provision for income taxes          
    Net loss  -33.4-7.0-8.7-8.1-8.1-8.7-7.9-7.9
   
Net loss per common share - basic (in USD per share)  ($7.86)($0.06)($0.07)($2.73)($0.04)($0.11)($0.14)($0.14)
Net loss per common share - diluted (in USD per share)  ($7.86)($0.06)($0.07)($2.73)($0.04)($0.11)($0.14)($0.14)
   
Weighted-average common shares used in computing net loss per common share – basic  4.2112.1115.83.067.977.954.954.9
Weighted-average common shares used in computing net loss per common share – diluted  4.2112.1115.83.067.977.954.954.9
   
Revenue from Contract with Customer, Product and Service [Extensible List]          
Cost, Product and Service [Extensible List]          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy